investor-company-about

Your Shopping Cart is empty.

${{ (item.variation.media ? item.variation.media.alt_translations : item.product.cover_media.alt_translations) | translateModel }}$ ${{ (item.variation.media ? item.variation.media.alt_translations : item.product.cover_media.alt_translations) | translateModel }}$

{{ childProduct.title_translations | translateModel }}

{{ getChildVariationShorthand(childProduct.child_variation) }}

{{ getSelectedItemDetail(selectedChildProduct, item).childProductName }} x {{ selectedChildProduct.quantity || 1 }}

{{ getSelectedItemDetail(selectedChildProduct, item).childVariationName }}

{{item.quantity}}x NT$0 {{ item.unit_point }} Point

Remove

${{addonItem.product.cover_media.alt_translations | translateModel}}$

{{addonItem.quantity}}x {{ mainConfig.merchantData.base_currency.alternate_symbol + "0" }}

Remove

Investor Home > Company > Corporate Overview

Corporate Overview

Company Profile

Company Name: DR.WU SKINCARE CO., LTD.
Stock Code: 6523
Date of Incorporation: March 10, 2003
TPEx Listing Date: June 16, 2016
Industry: Biotechnology and Medical Care
Principal Businesses: Research, development, and sales of medical aesthetic skincare products, health supplements, and beauty devices
Chairman: Eric Wu
General Manager: Eric Wu
Spokesperson: Temporary vacancy
Deputy Spokesperson: Eric Wu, CEO
Paid-in Capital: NT$450,476,250
Common Shares Issued: 45,047,625 shares
Unified Business No.: 80167706
Company Address: 13F., No. 70, Sec. 3, Nanjing E. Rd., Zhongshan Dist., Taipei City 104, Taiwan, R.O.C.
Telephone: +886-2-2517-9888
Fax: +886-2-2517-8333
Stock Transfer Agent: Transfer Agency Department of CTBC Bank
CPA Firm: PwC Taiwan

Corporate Milestones

2003

Skylight Biotechnology Corporation (the predecessor company of DR.WU Skincare Co., Ltd. ) was established in Taipei, followed by the launching of DR.WU Clinical Skincare brand with a paid-up capital of NT$5,000 thousand and skin care product development and sales as its main business.

2005

Formally selected Cosmed Drugstore chain as distribution channel.
Increased cash capital by NT$5,000 thousand; total paid-up capital reached NT$10,000 thousand.

2006

Successively utilized cosmetics distribution channels like SASA and drugstore chains such as Health Life and TinTin.

2007

Brand entered overseas markets in Hong Kong, the United States and New Zealand as well as Yahoo! Shopping; total sales locations reached 500 stores; launched product line which includes Hydrating, Whitening, Anti-acne, Repair, Basic care and Special six series.

2008

Brand launching at Watsons; overseas expansion (i.e., Singapore); total sales locations reached 900; won first prize in many magazine contests under the beauty category.

2009

Domestic sale of the first cosmeceutical brand in Taiwan, launching more than 100 products
Increased cash capital by NT$10,000 thousand; paid-up capital reached NT$20,000 thousand.

2011

Entered Malaysia, won major awards under the beauty category.
The Company moved to a new address at 5F. No.102, Sec.2 Roosevelt Rd., Zhongzheng Dist., Taipei City.

2012

Overseas market expansion to Canada.
CEO Eric Wu won TOP 100 MVP Managers Award.
Launched Vitamin C+ Whitening System, number of sales locations surpassed 1,200.
Received over 30 beauty awards from magazines, became the No. 1 local and medical cosmeceutical brand in Taiwan.

2013

Increased cash capital by NT$80,000 thousand ; profit capital reached NT$100,000 thousand and total paid-up capital reached NT$200,000 thousand.

2014

Renamed the Company DR.WU Skincare Co., Ltd. (2014.05.06).
Received investment from L Capital Taiwan Beauty Ltd. of LVMH Group, which is more than 10% of the Company’s major shareholders and corporate directors.
CEO Eric Wu received the EY Entrepreneur of The Year award.
Increased cash capital by NT$25,550 thousand; profit capital reached NT$56,388 thousand and total paid-up capital reached NT$281,938 thousand.

2015

The Company became publicly traded on the TPEX (2015.03.31).
The Company was listed on the TPEX’s Emerging Stock Market (2015.04.30).
Opened the first counter in Shanghai and entered Yanli beauty retail channels.

2016

The Company completed public listing on the TPEX (2016.06.16).
The Company continued to increase retail counters in Beijing and Shanghai.
Overseas market expansion (i.e., Myanmar).
Increased cash capital by NT$35,250 thousand; profit capital reached NT$140,969 thousand, and total paid-up capital reached NT$458,157 thousand.

2017

Entered Watsons in China and Malaysia.
CRM was launched online for integration with the QR code for one-product-one-code.
The Company relocated to the 9th floor, No. 100, Section 2, Roosevelt Road, Zhongzheng District, Taipei City.

2018

The company placed in the top 5% of companies in the 4th Corporate Governance.

2019

The Company relocated to the 13F, No. 70, Section 3, Nanjing East Road, Zhongshan District, Taipei City.

2020

Overseas market expansion to Japan.

2021

Product category extension to beauty supplements.

2022

Launched new brand- re’dermx
The Company received Hall of Fame 2022 with hero product- squalanex intensive repairing oil serum from @Cosme Taiwan, and won top 3 of the best cosmetics awards for five years consecutively.

2023

Launched TRI-RETINOID Revitalizing Series.
The Company won No.1 with hero product- squalanex rosehip revitalizing oil serum from the Hall of Fame 2023, @Cosme Taiwan.
The Company won Asia No.1 Mandelic Acid Skincare Brand by the world’s leading market research company - Euromonitor International.

2024

Awarded the “2024 Rising Star Award” in August.
Launched the new Instant Calming & Soothing Series.

2025

Launched the all-new “Hydrating Dual Collagen Peptide Drink,” breaking away from traditional single-format supplementation and bringing an innovative experience to the collagen health market.

Organizational Structure

Department	Functions
Chairman's Office	Determines the Group’s development and investment strategies.
Auditing Office	Audits internal rules and regulations,and makes proposals for improvement. Plans and executes audit proceedings.
General Manager's Office	Oversees the Company’s strategies and operational management. Monitors business targets and performance analysis.
Business Development Department	Plans and executes business markets locally and abroad. Handles customer development and management locally and abroad. Reviews sales targets,strategies and recommendations. Handles production,sales coordination,and sales projection. Product training.
Marketing Department	Brand image management. Public and media relations management. Strategic event planning and execution. Advertising and media procurement. Competitor monitoring and analysis.
Design Department	Advertising strategy, creative planning and design. Visual design intergration for business. Marketing distribution channels through visual communication. Product and package design.
Product Development Department	Handles planning,analysis and evaluation for new product development and upgrade. Oversees application and development of new ingredients. Determines product specifications and verifies stability. Gathers industry information and academic literature. Manages trademark and patents. Handles inspection of raw materials,processing and finished products;implements quality control and assurance procedures.
Procurement Department	Manages production/processing plan and schedule. Handles OEM factories,supplier evaluation and management. Procurement planning and execution. Logistics planning and management. Inventory management.
Administrative Department	Human Resources management and strategic planning. Employees benefits planning and processing. Handles legal matters. Manages company assets and general affairs. Plans and introduces information system.
Accounting Department	Preparation and analysis of financial report and budget. Establishment,evaluation and implementation of accounting system. Accouting and tax management. Preparation of business management reports.
Financial Department	Capital budgeting,planning and management. Monitors receipts,payments and outstanding accounts. Handles matters relating to company shares.

Investor Home